ArticleBMC pulmonary medicine2026
Abnormalities on chest high-resolution computed tomography in patients with cough-variant asthma.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is a limited understanding of the imaging features of chest high-resolution computed tomography (HRCT) in patients with cough variant asthma (CVA). We conducted this retrospective study to explore whether patients with CVA had relevant abnormalities on chest HRCT. PATIENTS AND
methodsWe retrospectively studied 406 patients with CVA at Beijing Chao-Yang Hospital between November 1, 2021, and October 31, 2022. We collected and analyzed the baseline data, lung function, and chest HRCT abnormalities of these patients.
resultsThe median age of patients with CVA was 43 years, and females accounted for 63.1% of the patients. The median symptom duration of CVA was 4 months. Most patients with CVA have normal lung function (47.3%) or mild obstructive lung dysfunction (45.6%). Only 18 patients (4.4%) had small airway dysfunction. The incidence of type 2 inflammation was 64.5% among 363 patients. A total of 80.0% of the patients had abnormal chest HRCT findings in the patients. The percentage of bronchiolar abnormalities was 45.8%; however, the percentage of bronchial abnormalities was 61.3%. When subgroup analyses were performed according to lung function, 73.4% of patients with normal lung function had abnormal chest HRCT findings. Among patients with mild obstructive lung dysfunction, 85.9% had abnormal chest HRCT findings.
conclusionChest HRCT abnormalities are common in patients with newly diagnosed CVA including those with normal lung function. This suggests chest CT abnormalities may precede detectable changes in pulmonary function. Furthermore, the proportion of these abnormalities increases as lung function declines. This implies that bronchial wall thickening and pulmonary emphysema may be involved in the deterioration of lung function in CVA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.